The development and marketing of ADCs are likely to signific...
The development and marketing of ADCs are likely to significantly benefit the bottom lines of pharmaceutical and biotech companies involved in their production. Companies like ImmunoGen and ADC Therapeutics are also highlighted as ones to watch in the ADC space.
Pfizer, Gilead, Roche Seen Benefitting the Most From Antibody-drug Conjugates
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment